Pictet Asset Management (Switzerland)’s West Pharmaceutical WST Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$13.3M	Buy	34,833 +777	+2%	+$278K	0.02%	561
2023 Q1	$11.8M	Buy	34,056 +485	+1%	+$142K	0.01%	584
2022 Q4	$7.9M	Sell	33,571 -1,985	-6%	-$470K	0.01%	644
2022 Q3	$8.75M	Buy	35,556 +210	+0.6%	+$64K	0.01%	610
2022 Q2	$10.7M	Sell	35,346 -928	-3%	-$302K	0.01%	582
2022 Q1	$14.9M	Buy	36,274 +381	+1%	+$149K	0.02%	552
2021 Q4	$16.8M	Buy	35,893 +806	+2%	+$347K	0.02%	556
2021 Q3	$14.9M	Buy	+35,087	New	+$14.8M	0.02%	583

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s WST Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its West Pharmaceutical (WST) stake by 2.3% in Q2 2023, buying an estimated $278K and bringing the position to 34,833 shares worth $13.3M. The position accounts for 0.02% of the portfolio, ranked #561.

Pictet Asset Management (Switzerland) first reported a position in WST in Q3 2021 and has held it in 8 quarters since. The position peaked at $16.8M in Q4 2021. 735 funds tracked by Wall St. Rank hold WST as of Q2 2023.

Pictet Asset Management (Switzerland) held 34,833 shares of West Pharmaceutical worth $13.3M as of Q2 2023.
Pictet Asset Management (Switzerland) bought 777 West Pharmaceutical shares in Q2 2023, an estimated $278K.
West Pharmaceutical made up 0.02% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #561 holding.
Pictet Asset Management (Switzerland) first reported a position in West Pharmaceutical in Q3 2021 and has held it in 8 quarters since.
Pictet Asset Management (Switzerland)'s West Pharmaceutical position peaked at $16.8M in Q4 2021.
735 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.